SCHEMBL9857140

SCHEMBL9857140

C=CCOC(=O)CP(=O)(c1ccccc1)c1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.64
SMN1; SMN2 Q16637 1/20 0.64
POLB P06746 1/20 0.58
USP2 O75604 1/20 0.53
CYP3A4 P08684 1/20 0.49
NPSR1 Q6W5P4 1/20 0.47
ALDH1A1 P00352 4/20 0.43
TSHR P16473 2/20 0.43
HSD17B10 Q99714 1/20 0.43
HTT P42858 1/20 0.42
ALOX15 P16050 1/20 0.41
GAA P10253 1/20 0.41
CYP2C9 P11712 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13498168 0.77 SMN1; SMN2 (0.76) PKMSMN1; SMN2POLBCYP3A4NPSR1
SCHEMBL10447316 0.75 PKM (0.56) PKMSMN1; SMN2USP2CYP3A4NPSR1
SCHEMBL15438170 0.74 POLB (0.58) POLBUSP2NPSR1ALDH1A1TSHR
SCHEMBL5076070 0.74 POLB (1.00) POLBUSP2NPSR1ALDH1A1HTT
SCHEMBL28470334 0.74 USP2 (0.62) POLBUSP2NPSR1ALDH1A1TSHR
SCHEMBL203679 0.73 ALDH1A1 (0.61) PKMSMN1; SMN2CYP3A4NPSR1ALDH1A1
SCHEMBL1501229 0.72 PKM (0.54) PKMSMN1; SMN2CYP3A4NPSR1ALDH1A1
SCHEMBL331731 0.72 PKM (0.49) PKMSMN1; SMN2POLBUSP2CYP3A4
Hydrochloric Acid SCHEMBL25259767 0.71 ALDH1A1 (0.59) PKMSMN1; SMN2CYP3A4NPSR1ALDH1A1
SCHEMBL5823328 0.71 TSHR (0.44) PKMSMN1; SMN2CYP3A4NPSR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4996235-A Selectively inhibiting the uptake of serotonin and norepinephrine ELI LILLY AND COMPANY (US) 1991-02-26 US disclosed
EP-0318233-A2 Improvements in or relating to serotonin and norepinephrine uptake inhibitors ELI LILLY AND COMPANY (US) 1989-05-31 EP disclosed